Paper412786
Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections.
Pavlovskis OR and 3 others. Infect Immun, 1977. Cited by 109 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections. Papers, record 412786. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/412786
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antitoxins | Major topic |
| Burns | Major topic |
| Immunity, Maternally-Acquired | Major topic |
| Pseudomonas Infections | Major topic |
| Pseudomonas aeruginosa | Major topic |
| Animals | |
| Exotoxins | |
| Female | |
| Liver | |
| Mice | |
| Sepsis |
Source PubMed
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 65,205 | Response of cultured mammalian cells to the exotoxins of Pseudomonas aeruginosa and Corynebacterium diphtheriae: differential cytotoxicity. | Can J Microbiol | 1977 | https://conductscience.org/library/papers/65205 | PubMed |
| 2 | 68,931 | Incidence of exotoxin production by Pseudomonas species. | Infect Immun | 1977 | https://conductscience.org/library/papers/68931 | PubMed |
| 3 | 188,760 | Mechanism of action of Pseudomonas aeruginosa exotoxin Aiadenosine diphosphate-ribosylation of mammalian elongation factor 2 in vitro and in vivo. | Infect Immun | 1977 | https://conductscience.org/library/papers/188760 | PubMed |
| 4 | 404,244 | Exotoxin production by clinical isolates of pseudomonas aeruginosa. | Infect Immun | 1977 | https://conductscience.org/library/papers/404244 | PubMed |
| 5 | 407,250 | Serum antibody to Pseudomonas aeruginosa exotoxin measured by a passive hemagglutination assay. | J Clin Microbiol | 1977 | https://conductscience.org/library/papers/407250 | PubMed |
| 6 | 825,470 | Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection. | Infect Immun | 1976 | https://conductscience.org/library/papers/825470 | PubMed |
| 7 | 4,370,620 | Extracellular toxins of Pseudomonas aeruginosa. | J Infect Dis | 1974 | https://conductscience.org/library/papers/4370620 | PubMed |
| 8 | 815,443 | Pseudomonas aeruginosa exotoxin in mice: histopathology and serum enzyme changes. | J Infect Dis | 1976 | https://conductscience.org/library/papers/815443 | PubMed |
| 9 | 4,200,593 | Exotoxins of Pseudomonas aeruginosa. 3. Characteristics of antitoxin A. | J Infect Dis | 1973 | https://conductscience.org/library/papers/4200593 | PubMed |
| 10 | 4,200,592 | Exotoxins of Pseudomonas aeruginosa. II. Concentration, purification, and characterization of exotoxin A. | J Infect Dis | 1973 | https://conductscience.org/library/papers/4200592 | PubMed |
| 11 | 4,206,027 | Pseudomonas aeruginosa exotoxin in mice: localization and effect on protein synthesis. | Infect Immun | 1974 | https://conductscience.org/library/papers/4206027 | PubMed |
| 12 | 4,202,883 | Purification and characterization of Pseudomonas aeruginosa exotoxin. | Infect Immun | 1974 | https://conductscience.org/library/papers/4202883 | PubMed |
| 13 | 4,624,815 | Pseudomonas aeruginosa exotoxin: effect on cell cultures. | J Infect Dis | 1972 | https://conductscience.org/library/papers/4624815 | PubMed |
| 14 | 166,383 | NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin,. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/166383 | PubMed |
| 15 | 4,959,184 | The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. 3. Identity of the lethal toxins produced in vitro and in vivo. | J Infect Dis | 1966 | https://conductscience.org/library/papers/4959184 | PubMed |
| 16 | 4,968,365 | Pseudomonas exotoxin shock. A preliminary report of studies in dogs. | JAMA | 1968 | https://conductscience.org/library/papers/4968365 | PubMed |
| 17 | 820,647 | Pseudomonas aeruginosa exotoxin: purification by preparative polyacrylamide gel electrophoresis and the development of a highly specific antitoxin serum. | Infect Immun | 1976 | https://conductscience.org/library/papers/820647 | PubMed |
| 18 | 805,812 | Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model. | J Infect Dis | 1975 | https://conductscience.org/library/papers/805812 | PubMed |
Cited by58
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 109 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 25,510,881 | The prrF-encoded small regulatory RNAs are required for iron homeostasis and virulence of Pseudomonas aeruginosa. | Infect Immun | 2015 | https://conductscience.org/library/papers/25510881 | PubMed |
| 24,670,666 | "Specificity Determinants" Improve Therapeutic Indices of Two Antimicrobial Peptides Piscidin 1 and Dermaseptin S4 Against the Gram-negative Pathogens Acinetobacter baumannii and Pseudomonas aeruginosa. | Pharmaceuticals (Basel) | 2014 | https://conductscience.org/library/papers/24670666 | PubMed |
| 23,630,954 | Regulation of Rab5 function during phagocytosis of live Pseudomonas aeruginosa in macrophages. | Infect Immun | 2013 | https://conductscience.org/library/papers/23630954 | PubMed |
| 21,219,588 | Rational design of α-helical antimicrobial peptides to target Gram-negative pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: utilization of charge, 'specificity determinants,' total hydrophobicity, hydrophobe type and location as design parameters to improve the therapeutic ratio. | Chem Biol Drug Des | 2011 | https://conductscience.org/library/papers/21219588 | PubMed |
| 21,203,470 | A dominant-negative approach that prevents diphthamide formation confers resistance to Pseudomonas exotoxin A and diphtheria toxin. | PLoS One | 2010 | https://conductscience.org/library/papers/21203470 | PubMed |
| 19,183,501 | Active immunization using exotoxin A confers protection against Pseudomonas aeruginosa infection in a mouse burn model. | BMC Microbiol | 2009 | https://conductscience.org/library/papers/19183501 | PubMed |
| 18,098,173 | Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides. | Biopolymers | 2008 | https://conductscience.org/library/papers/18098173 | PubMed |
| 17,158,938 | Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17158938 | PubMed |
| 11,598,071 | Dual-function vaccine for Pseudomonas aeruginosa: characterization of chimeric exotoxin A-pilin protein. | Infect Immun | 2001 | https://conductscience.org/library/papers/11598071 | PubMed |
| 11,500,471 | PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice. | Infect Immun | 2001 | https://conductscience.org/library/papers/11500471 | PubMed |
| 7,591,089 | Functional properties of isotype-switched immunoglobulin M (IgM) and IgG monoclonal antibodies to Pseudomonas aeruginosa lipopolysaccharide. | Infect Immun | 1995 | https://conductscience.org/library/papers/7591089 | PubMed |
| 7,537,248 | Pseudomonas aeruginosa exoenzyme S induces proliferation of human T lymphocytes. | Infect Immun | 1995 | https://conductscience.org/library/papers/7537248 | PubMed |
| 6,821,202 | Antibody response to Pseudomonas aeruginosa exoproducts in cancer patients. | J Clin Microbiol | 1982 | https://conductscience.org/library/papers/6821202 | PubMed |
| 6,807,846 | Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats. | Infect Immun | 1982 | https://conductscience.org/library/papers/6807846 | PubMed |
| 6,800,950 | Microscopic characterization of ocular damage produced by Pseudomonas aeruginosa toxin A. | Infect Immun | 1981 | https://conductscience.org/library/papers/6800950 | PubMed |
| 6,788,700 | Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with exotoxin A toxoids. | Infect Immun | 1981 | https://conductscience.org/library/papers/6788700 | PubMed |
| 6,783,532 | Polyvalent antisera to Pseudomonas ribosomal vaccines: protection of mice against clinically isolated strains. | Infect Immun | 1980 | https://conductscience.org/library/papers/6783532 | PubMed |
| 6,775,004 | Production of alkaline protease by Pseudomonas aeruginosa. | J Clin Microbiol | 1980 | https://conductscience.org/library/papers/6775004 | PubMed |
| 6,772,570 | Toxin A-deficient mutants of Pseudomonas aeruginosa PA103: isolation and characterization. | Infect Immun | 1980 | https://conductscience.org/library/papers/6772570 | PubMed |
| 6,551,339 | Passive protection against Pseudomonas aeruginosa infection in an experimental leukopenic mouse model. | Infect Immun | 1983 | https://conductscience.org/library/papers/6551339 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/412786
GET https://conductscience.org/api/papers/v1/412786/cited_by?page=2